AR103801A1 - Formas cristalinas de un compuesto de pirrolopiridina - Google Patents

Formas cristalinas de un compuesto de pirrolopiridina

Info

Publication number
AR103801A1
AR103801A1 ARP160100511A ARP160100511A AR103801A1 AR 103801 A1 AR103801 A1 AR 103801A1 AR P160100511 A ARP160100511 A AR P160100511A AR P160100511 A ARP160100511 A AR P160100511A AR 103801 A1 AR103801 A1 AR 103801A1
Authority
AR
Argentina
Prior art keywords
compound
pirrolopiridine
crystal forms
aminopiperidin
cyclopropanecarboxamide
Prior art date
Application number
ARP160100511A
Other languages
English (en)
Original Assignee
Genentech Inc
Array Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55521844&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR103801(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc, Array Biopharma Inc filed Critical Genentech Inc
Publication of AR103801A1 publication Critical patent/AR103801A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Reivindicación 1: Una forma cristalina de un compuesto seleccionado de: (R)-N-(4-(3-aminopiperidin-1-il)-5-bromo-1H-pirrol[2,3-b]piridin-3-il)ciclopropanocarboxamida; y sales, solvatos e hidratos de la misma aceptables para uso farmacéutico.
ARP160100511A 2015-02-26 2016-02-26 Formas cristalinas de un compuesto de pirrolopiridina AR103801A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562121396P 2015-02-26 2015-02-26

Publications (1)

Publication Number Publication Date
AR103801A1 true AR103801A1 (es) 2017-06-07

Family

ID=55521844

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160100511A AR103801A1 (es) 2015-02-26 2016-02-26 Formas cristalinas de un compuesto de pirrolopiridina

Country Status (21)

Country Link
US (2) US20160251350A1 (es)
EP (1) EP3262042A1 (es)
JP (1) JP2018506562A (es)
KR (1) KR20170118762A (es)
CN (1) CN107406447A (es)
AR (1) AR103801A1 (es)
AU (1) AU2016225070A1 (es)
BR (1) BR112017018230A2 (es)
CA (1) CA2976665A1 (es)
CL (1) CL2017002180A1 (es)
CO (1) CO2017009662A2 (es)
CR (1) CR20170439A (es)
HK (1) HK1246786A1 (es)
IL (1) IL254115A0 (es)
MA (1) MA41599A (es)
MX (1) MX2017010888A (es)
PE (1) PE20171327A1 (es)
PH (1) PH12017501532A1 (es)
RU (1) RU2017133093A (es)
SG (1) SG11201706824TA (es)
WO (1) WO2016138458A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021014640A8 (pt) * 2019-01-29 2022-12-20 Huya Bioscience Int Llc Sais de sulcardina
US20230250068A1 (en) * 2019-02-12 2023-08-10 Inpact Biomedicines, Inc. Crystalline forms of a jak2 inhibitor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
AR071717A1 (es) * 2008-05-13 2010-07-07 Array Biopharma Inc Pirrolo[2,3-b]piridinas inhibidoras de quinasas chk1 y chk2,composiciones farmaceuticas que las contienen,proceso para prepararlas y uso de las mismas en el tratamiento y prevencion del cancer.
US8481557B2 (en) * 2009-04-11 2013-07-09 Array Biopharma Inc. Method of treatment using checkpoint kinase 1 inhibitors
RU2017127088A (ru) * 2010-11-16 2019-02-04 Эррэй Биофарма Инк. Комбинация ингибиторов чекпойнт-киназы 1 и ингибиторов киназы wee 1
WO2015027090A1 (en) * 2013-08-22 2015-02-26 Genentech, Inc. Intermediates and processes for preparing compounds
CN105705499B (zh) * 2013-08-22 2018-10-12 基因泰克公司 用于制备化合物的方法

Also Published As

Publication number Publication date
JP2018506562A (ja) 2018-03-08
AU2016225070A1 (en) 2017-09-07
US20180282324A1 (en) 2018-10-04
MX2017010888A (es) 2017-12-15
MA41599A (fr) 2018-01-02
RU2017133093A3 (es) 2019-08-23
PE20171327A1 (es) 2017-09-12
US20160251350A1 (en) 2016-09-01
WO2016138458A1 (en) 2016-09-01
BR112017018230A2 (pt) 2018-04-17
KR20170118762A (ko) 2017-10-25
CA2976665A1 (en) 2016-09-01
EP3262042A1 (en) 2018-01-03
CL2017002180A1 (es) 2018-03-16
CN107406447A (zh) 2017-11-28
PH12017501532A1 (en) 2018-02-05
SG11201706824TA (en) 2017-09-28
CO2017009662A2 (es) 2018-02-28
IL254115A0 (en) 2017-10-31
CR20170439A (es) 2018-01-08
HK1246786A1 (zh) 2018-09-14
RU2017133093A (ru) 2019-03-26

Similar Documents

Publication Publication Date Title
CL2017000902A1 (es) Dihidropirrolopiridinas inhibidoras de ror-gamma
LT3494115T (lt) N-(fenilsulfonil)benzamido dariniai kaip bcl-2 inhibitoriai
DK3529241T3 (da) Pireridinderivater som inhibitorer af ubiquitin-specifik protease 7
AR096758A1 (es) Inhibidores cristalinos de bromodominios
CL2017002090A1 (es) Inhibidores selectivos de bace1
DOP2017000101A (es) Formas cristalinas de 5-cloro-n4-[2-(dimetilfosforil)fenil]-n2-{2-metoxi-4-[4-(4-metilpiperazin-1-il)piperidin-1-il]pirimidina-2,4-diamina
CR20140332A (es) Inhibidores de bromodominios
DK3385262T3 (da) 4-(3h-indol-5-yl)-n-(pyridin-2-yl)pyrimidin-2-aminderivater som proteinkinaseinhibitorer, fremstillingsfremgangsmåde og medicinsk anvendelse deraf
MA39749A (fr) Dérivés de pipéridine-dione
DK3582780T3 (da) Aminopyrimidinforbindelser, der er anvendelige som SSAO-inhibitorer
DK3687996T3 (da) Salte af pyrrolotriazinderivater anvendelige som tam-inhibitorer
DK3672975T3 (da) Kondenserede, heterocykliske derivater som bcl-2-hæmmere til behandling af neoplastiske sygdomme
DK3870574T3 (da) Aminopyridin/pyrazinderivater som ctps1-inhibitorer
DK3768674T3 (da) Aminopyrimidinderivater som ctps1-hæmmere
DK3412672T3 (da) Krystalform A af 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-D]pyrimidin-4-amin som TLR7-agonist, fremstillingsfremgangsmåde og anvendelse deraf
MA40059A (fr) Inhibiteurs de la phosphatidylinositol 3-kinase
CR20170077A (es) Derivados de heterociclilo opcionalmente condensados de pirimidina útiles para el tratamiento de enfermedades inflamatorias, metabólicas, oncológicas y autoinmunitarias
BR112017004673A2 (pt) formas cristalinas de 2-(4-(4-etoxi-6-oxo-1,6-diidropiridin-3-ila)-2-fluorofenil)-n-(5-(1,1,1-trifluoro-2-metilpropan-2-il)isoxazol-3-il) acetamida
WO2014153495A3 (en) Novel stat3 inhibitors
NI201500139A (es) Formas cristalinas de inhibidores de tirosina cinasa y sus sales
DK3797107T3 (da) Heterokondenserede pyridonforbindelser og anvendelse deraf som idh- hæmmere
AR104935A1 (es) Formas cristalinas de un inhibidor de histona deacetilasa
CR20190344A (es) Activador de nrf2
CO2020006206A2 (es) Polimorfos y formas sólidas de un compuesto de pirimidinilamino-pirazol y métodos de producción
AR103801A1 (es) Formas cristalinas de un compuesto de pirrolopiridina

Legal Events

Date Code Title Description
FB Suspension of granting procedure